Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety and Efficacy Study of Switching From Epzicom to Truvada

ClinicalTrials.gov ID: NCT00724711

Public ClinicalTrials.gov record NCT00724711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 1:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Open Label Phase IV Study to Evaluate the Rationale of Switching From Fixed Dose Abacavir (ABC)/Lamivudine (3TC) to Fixed Dose Tenofovir DF (TDF)/Emtricitabine (FTC) in Virologically Suppressed, HIV-1 Infected Patients Maintained on a Ritonavir Boosted Protease Inhibitor Containing Antiretroviral Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This protocol describes a prospective, randomized, open-label, multicenter study to evaluate the safety and efficacy of switching from fixed dose abacavir (ABC)/lamivudine (3TC) to fixed dose emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) in virologically suppressed, human immunodeficiency virus type 1 (HIV-1) infected subjects maintained on a ritonavir-boosted protease inhibitor (PI/r)-containing antiretroviral (ARV) regimen. Duration of treatment is 48 weeks.

Study identification

NCT ID
NCT00724711
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Gilead Sciences
Industry
Enrollment
312 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2008
Primary completion
Feb 28, 2011
Completion
Mar 31, 2011
Last update posted
May 27, 2012

2008 – 2011

United States locations

U.S. sites
73
U.S. states
19
U.S. cities
50
Facility City State ZIP Site status
Health For Life Clinic, PLLC Little Rock Arkansas 72207
Vista Medical Partners Beverly Hills California 90210
AHF Beverly Hills California 90211
Pacific Oaks Medical Group Beverly Hills California 90211
Center for Special Immunology Fountain Valley California 92708
Living Hope Clinical Foundation Long Beach California 90813
Jeffrey Goodman Special Care Clinic Los Angeles California 90028
Peter J. Ruane, MD, Inc. Los Angeles California 90036
Anthony M Mills, MD Los Angeles California 90069
Orange Coast Medical Group Newport Beach California 92663
Tarzana Treatment Center Northridge California 91324
Alameda County Medical Center Oakland California 94602
Health Management Institute, Inc. San Francisco California 94114
Metropolis Medical San Francisco California 94115
Kaiser Permanente Denver Colorado 80205
Blick Medical Associates Norwalk Connecticut 06851
Biogenomx Research Institute, LLC Fort Lauderdale Florida 33306
Life Way Inc. Fort Lauderdale Florida 33308
Therafirst Medical Centers Fort Lauderdale Florida 33308
HIV Clinical Research Fort Lauderdale Florida 33311
Gary Richmond, MD, PA, Inc. Fort Lauderdale Florida 33316
University of Florida Jacksonville Florida 32206
The Kinder Medical Group Miami Florida 33133
University of Miami Miami Florida 33136
South Florida Infectious Diseases and Tropical Medicine Center Miami Florida 33176
Community Health of South Florida Inc. Miami Florida 33190
Wohlfeiler, Piperato and Associates, LLC Miami Beach Florida 33139
Orlando Immunology Center Orlando Florida 32803
Infectious Diseases Associates of NW FL Pensacola Florida 32504
Associates in Infectious Diseases Port Saint Lucie Florida 34952
Barry M. Rodwick, M.D. Safety Harbor Florida 34695
USF Health Tampa Florida 33602
Infectious Disease Research Institute, Inc. Tampa Florida 33614
Clinical Pharmacology Services Tampa Florida 33617
Atlanta Infectious Disease Group, PC Atlanta Georgia 30309
Infectious Disease Solutions Atlanta Georgia 30309
Family Healthcare of Atlanta PC Atlanta Georgia 30318
Chatham County Health Department Savannah Georgia 31401
Howard Brown Health Center Chicago Illinois 60613
NorthStar Medical Center Chicago Illinois 60657
University of Louisville Louisville Kentucky 40202
Chase Brexton Health Services Baltimore Maryland 21201
MetroWest Medical Center Framingham Massachusetts 01702
Community Research Initiative of New England - WEST Springfield Massachusetts 01107
The Research Institute Springfield Massachusetts 01107
Be Well Medical Center Berkley Michigan 48072
Henry Ford Hospital Detroit Michigan 48202
Michigan State University, College of Osteopathic Medicine East Lansing Michigan 48824
St. John Hospital Internal Medicine Clinic - Mack Office Building Grosse Point Woods Michigan 48236
Hennepin County Medical Center Minneapolis Minnesota 55145
Abbott Northwestern Hospital Minneapolis Minnesota 55404
ID Associates, PA Hillsborough New Jersey 08844
Saint Michael's Medical Center Newark New Jersey 07102
South Jersey Infectious Disease Somers Point New Jersey 08244
Upstate Infectious Diseases Associates Albany New York 23309
Greiger Clinic Mount Vernon New York 10550
Ricky K. Hsu, MD, PC New York New York 10011
AIDS Community Health Center Rochester New York 14604
University of Rochester Medical Center Rochester New York 14642
ID Consultants, P.A. Charlotte North Carolina 28209
East Carolina University The Brody School of Medicine Greenville North Carolina 27858
Wake Forest University School of Medicine Winston-Salem North Carolina 27157
Summa Health System Care Center Akron Ohio 44394
Central Texas Clinical Research Austin Texas 78705
Baylor University Medical Center Dallas Texas 75204
UT Southwestern Medical Center at Dallas Dallas Texas 75235
North Texas Inf. Disease Consultants Dallas Texas 75246
Tarrant County Infectious Disease Associates Fort Worth Texas 76104
Valley AIDS Counsel Harlingen Texas 78550
Therapeutic Concepts, PA Houston Texas 77004
Gordon E. Crofoot, MD, PA Houston Texas 77098
Daniel Coulston, MD Spokane Washington 99204
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00724711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2012 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00724711 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →